Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gestur Vidarsson

Showing results (1-10 of 213) with videos related to

Pageof 22
Sort By:
Frontiers in Immunology|July 25, 2013
Antibodies and their receptors: different potential roles in mucosal defenseRachel E Horton, Gestur Vidarsson
Cellular and Molecular Life Sciences : CMLS|March 11, 2010
The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseasesAlina Sesarman, Gestur Vidarsson, Cassian Sitaru
Frontiers in Immunology|April 5, 2018
Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune DiseasesGillian Dekkers, Theo Rispens, Gestur Vidarsson
Frontiers in Immunology|November 5, 2014
IgG subclasses and allotypes: from structure to effector functionsGestur Vidarsson, Gillian Dekkers, Theo Rispens
Glycoconjugate Journal|January 29, 2022
Antibody glycosylation in COVID-19Tamas Pongracz, Gestur Vidarsson, Manfred Wuhrer
Nature Immunology|August 23, 2023
Publisher Correction: Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapyFalk Nimmerjahn, Gestur Vidarsson, Mark S Cragg
Nature Immunology|July 6, 2023
Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapyFalk Nimmerjahn, Gestur Vidarsson, Mark S Cragg
Immunology Letters|February 6, 2014
IgG-effector functions: "the good, the bad and the ugly"Rick Kapur, Helga K Einarsdottir, Gestur Vidarsson
Nature Immunology|July 12, 2023
Publisher Correction: Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapyFalk Nimmerjahn, Gestur Vidarsson, Mark S Cragg
Antibodies (Basel, Switzerland)|September 24, 2019
The Ligands for Human IgG and Their Effector FunctionsSteven W de Taeye, Theo Rispens, Gestur Vidarsson
Pageof 22

Showing results (1-10 of 213) with videos related to

Sort By:
Pageof 22
Frontiers in Immunology|July 25, 2013
Antibodies and their receptors: different potential roles in mucosal defenseRachel E Horton, Gestur Vidarsson
Cellular and Molecular Life Sciences : CMLS|March 11, 2010
The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseasesAlina Sesarman, Gestur Vidarsson, Cassian Sitaru
Frontiers in Immunology|April 5, 2018
Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune DiseasesGillian Dekkers, Theo Rispens, Gestur Vidarsson
Frontiers in Immunology|November 5, 2014
IgG subclasses and allotypes: from structure to effector functionsGestur Vidarsson, Gillian Dekkers, Theo Rispens
Glycoconjugate Journal|January 29, 2022
Antibody glycosylation in COVID-19Tamas Pongracz, Gestur Vidarsson, Manfred Wuhrer
Nature Immunology|August 23, 2023
Publisher Correction: Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapyFalk Nimmerjahn, Gestur Vidarsson, Mark S Cragg
Nature Immunology|July 6, 2023
Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapyFalk Nimmerjahn, Gestur Vidarsson, Mark S Cragg
Immunology Letters|February 6, 2014
IgG-effector functions: "the good, the bad and the ugly"Rick Kapur, Helga K Einarsdottir, Gestur Vidarsson
Nature Immunology|July 12, 2023
Publisher Correction: Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapyFalk Nimmerjahn, Gestur Vidarsson, Mark S Cragg
Antibodies (Basel, Switzerland)|September 24, 2019
The Ligands for Human IgG and Their Effector FunctionsSteven W de Taeye, Theo Rispens, Gestur Vidarsson
Pageof 22